Invesaro

Stocks ANGO Earnings

Earnings

Angiodynamics Inc (ANGO) earnings

Quarterly results of Angiodynamics Inc as filed with the SEC: revenue, net income and earnings per share for each of the last 8 quarters, the latest results release and when the next one is expected.

Free, no password. An email when ANGO files with the SEC.

Next earnings date

Angiodynamics Inc is expected to report around January 5, 2027. That is an estimate from its filing rhythm (a year after the same report last year), not a date the company has announced.

Latest quarter: Q1 FY2027

In Q1 FY2027 (ended August 31, 2026) Angiodynamics Inc reported revenue of $80.9M (+6.9% on the same quarter a year earlier) and a net loss of $7.1M.

Diluted earnings per share were -$0.17.

Filed with the SEC on October 8, 2026.

The latest results release

AngioDynamics reported first quarter net sales of $80.9 million and narrowed its net loss amid double-digit Med Tech growth.

Net sales rose 6.9% year over year to $80.9 million, led by a 13.2% increase in Med Tech net sales to $39.9 million.

October 8, 2026 · Read the release explained

Revenue by quarter
Q2 25: $72.8M $72.8M Q2 25Q3 25: $72M $72M Q3 25Q4 25: $80.2M $80.2M Q4 25Q1 26: $75.7M $75.7M Q1 26Q2 26: $79.4M $79.4M Q2 26Q3 26: $78.4M $78.4M Q3 26Q4 26: $86.6M $86.6M Q4 26Q1 27: $80.9M $80.9M Q1 27
Net income by quarter
Q2 25: -$10.7M -$10.7M Q2 25Q3 25: -$4.4M -$4.4M Q3 25Q4 25: -$6.1M -$6.1M Q4 25Q1 26: -$10.9M -$10.9M Q1 26Q2 26: -$6.4M -$6.4M Q2 26Q3 26: -$8.1M -$8.1M Q3 26Q4 26: -$11.4M -$11.4M Q4 26Q1 27: -$7.1M -$7.1M Q1 27

Quarter by quarter

QuarterEndedRevenuevs year agoNet incomeEPS
Q1 FY2027August 31, 2026$80.9M+6.9%-$7.1M-$0.17
Q4 FY2026May 31, 2026$86.6M+8%-$11.4M-
Q3 FY2026February 28, 2026$78.4M+8.9%-$8.1M-$0.19
Q2 FY2026November 30, 2025$79.4M+9%-$6.4M-$0.15
Q1 FY2026August 31, 2025$75.7M--$10.9M-$0.26
Q4 FY2025May 31, 2025$80.2M--$6.1M-
Q3 FY2025February 28, 2025$72M--$4.4M-$0.11
Q2 FY2025November 30, 2024$72.8M--$10.7M-$0.26

Fourth quarters are the fiscal year minus the first three, as most companies report no separate Q4 figures.

Results filings

When is Angiodynamics Inc's next earnings date?

Angiodynamics Inc is expected to report around January 5, 2027. That is an estimate from its filing rhythm (a year after the same report last year), not a date the company has announced.

What were Angiodynamics Inc's latest quarterly results?

For Q1 FY2027, which ended August 31, 2026, Angiodynamics Inc reported revenue of $80.9M and a net loss of $7.1M. The figures come from its filing with the SEC.

Is Angiodynamics Inc's revenue growing?

Revenue in Q1 FY2027 was $80.9M, up 6.9% from $75.7M in the same quarter a year earlier.

Get an email when ANGO reports

Follow ANGO and we email you its next results the day they are filed, with the numbers explained.

Free, no password. An email when ANGO files with the SEC.

Source: quarterly figures Angiodynamics Inc tags in its 10-Q and 10-K filings (SEC EDGAR XBRL). Not investment advice.

Everything about Angiodynamics Inc